Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

This study has been terminated.
(B1411001 was terminated after completion of 4 cohorts of the multiple ascending dose phase, as additional data were deemed unnecessary. No safety concerns.)
Information provided by:
Pfizer Identifier:
First received: October 5, 2009
Last updated: November 23, 2010
Last verified: November 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)